Sara J. Cromer, MD

Massachusetts General Hospital, United States

Disclosure information not submitted.

Presentation(s):

• The risk of cardiovascular (CV) events after initiation of SGLT2i, GLP-1RA, DPP4i, or SUs in patients with T2D and low-to-moderate CV risk

  Wednesday, August 28, 2024
  9:00 AM – 9:15 AM CEST